Tyler Sandahl (@sandahltyler) 's Twitter Profile
Tyler Sandahl

@sandahltyler

Mama and Heme/Onc Pharmacist. Opinions are my own

ID: 1334998230942314501

calendar_today04-12-2020 23:09:40

15 Tweet

73 Followers

138 Following

Tyler Sandahl (@sandahltyler) 's Twitter Profile Photo

Shoutout to my fellow pharmacists for another great catch! 👏🏻👏🏻👏🏻 #CovidVaccine nytimes.com/2020/12/16/hea…

Michelle Obama (@michelleobama) 's Twitter Profile Photo

With her strong and poignant words, Amanda Gorman reminds us of the power we each hold in upholding our democracy. Keep shining, Amanda! I can't wait to see what you do next. 💕 #BlackGirlMagic Photo credit: Rob Carr

With her strong and poignant words, <a href="/TheAmandaGorman/">Amanda Gorman</a> reminds us of the power we each hold in upholding our democracy. Keep shining, Amanda! I can't wait to see what you do next. 💕 #BlackGirlMagic

Photo credit: Rob Carr
Tyler Sandahl (@sandahltyler) 's Twitter Profile Photo

Beautiful and heartbreaking. Thank you @KB_McCullough for bearing your soul for us and putting words to a feeling many of us know so well but can’t quite describe. ❤️❤️❤️

JCO Oncology Practice (@jcoop_asco) 's Twitter Profile Photo

Compared with historic controls, omission of premedications after daratumumab cycle 1 did not increase incidence of infusion reactions compared with those who received premeds; as a result, de-escalation may be considered. ➡️ brnw.ch/21wHFDE Tyler Sandahl #mmsm

Compared with historic controls, omission of premedications after daratumumab cycle 1 did not increase incidence of infusion reactions compared with those who received premeds; as a result, de-escalation may be considered. ➡️ brnw.ch/21wHFDE <a href="/SandahlTyler/">Tyler Sandahl</a> #mmsm
HOPARX (@hoparx) 's Twitter Profile Photo

HOPA Members Michael B. Hardler Tyler Sandahl Rachel Bailen recently contributed to this late-breaking news article, showing how CAR-T Cell treatment is moving up the rung in Multiple Myeloma and breaking ground in Chronic Lymphocytic Leukemia: bit.ly/3SkQRDl

HOPA Members <a href="/Pharmer_Mike_/">Michael B. Hardler</a> <a href="/SandahlTyler/">Tyler Sandahl</a> <a href="/RachelBubik/">Rachel Bailen</a> recently contributed to this late-breaking news article, showing how CAR-T Cell treatment is moving up the rung in Multiple Myeloma and breaking ground in Chronic Lymphocytic Leukemia: bit.ly/3SkQRDl
Zahra M, PharmD, MBA, BCOP, FHOPA (@kczmj) 's Twitter Profile Photo

Bispecific antibodies are changing treatment in Hem/Onc.. but adoption has been mixed due to logistics! Out now in JADPRO, we aim to tackle some FAQ! 🙏🏻 to Amir Ali, PharmD, BCOP James Davis, PharmD, BCOP Tyler Sandahl Victoria Nachar Robert Mancini, PharmD, BCOP, FHOPA! #oncopharm #TwitterRx jadpro.com/online-first/2…

Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

Great to see in JCO Oncology Practice - Mayo experience with outpt teclistamab step-up dosing in #MMsm. This is where the field is headed, and impressive to see how quickly Mayo Myeloma campuses moved there - and how much this ⬇️ time toxicity for patients! ascopubs.org/doi/10.1200/OP…

Great to see in <a href="/JCOOP_ASCO/">JCO Oncology Practice</a> - Mayo experience with outpt teclistamab step-up dosing in #MMsm. 

This is where the field is headed, and impressive to see how quickly <a href="/MayoMyeloma/">Mayo Myeloma</a> campuses moved there - and how much this  ⬇️ time toxicity for patients!

ascopubs.org/doi/10.1200/OP…